Linc AB (LINC) AI Stock Analysis

• Market Cap: kr4.42B
• Dividend Yield: N/A
• Average Volume (3M): 30.73K
• Price to Earnings (P/E): 18.1
• Beta (1Y): 0.61
• Revenue Growth: 37.32%
• EPS Growth: -39.07%
• Country: SE
• Employees: 2
• Sector: Financial
• Sector Strength: 82
• Industry: Asset Management
• EPS (TTM): 4.22
• Shares Outstanding: 57,910,446
• 10 Day Avg. Volume: 25,475
• 30 Day Avg. Volume: 30,730
• PEG Ratio: 0.10
• Price to Book (P/B): 3.14
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 4.45K
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 57 Neutral
• Price Target: ―

Linc AB's strong equity position and low leverage provide a solid financial foundation, but volatility in profitability and cash flow generation pose challenges. The technical analysis indicates bearish momentum, while the low P/E ratio suggests the stock is undervalued. The lack of dividend yield and absence of earnings call and corporate events data limit additional insights. Overall, the stock is moderately rated, reflecting the need for stability in financial performance and improved market sentiment.

Linc AB Business Overview & Revenue Model

Company Description

Linc AB (LINC) is a Swedish investment company that operates primarily in the healthcare sector. The company focuses on investing in small to medium-sized enterprises that are involved in biotechnology, medical technology, and pharmaceuticals. Linc AB aims to support the growth and development of its portfolio companies by providing strategic guidance and financial resources.

How the Company Makes Money

Linc AB generates revenue primarily through its investment activities. The company makes money by acquiring equity stakes in promising healthcare companies and later selling these stakes at a profit. The company may also receive dividends from its investments, depending on the profitability of the portfolio companies. Additionally, Linc AB leverages its expertise and network within the healthcare sector to enhance the value of its investments, contributing to potential capital gains. Significant factors contributing to its earnings include the successful identification of high-potential companies and effective portfolio management.

Linc AB Financial Statement Overview

Summary

Linc AB demonstrates a strong equity position and no leverage, providing a stable financial foundation. However, volatility in profitability metrics and inconsistent cash flow generation present challenges. The company needs to focus on stabilizing its profitability and improving cash flow reliability to enhance its financial performance.

Income Statement

Linc AB shows strong growth in revenue over recent years, with a notable increase from 2023 to 2024. However, profitability metrics present a mixed picture. The gross profit and net profit margins are high for 2024, yet there are inconsistencies with previous years, reflecting volatility. EBIT and EBITDA margins are also strong for 2024, but the historical performance shows periods of negative margins, indicating instability in the company's operational efficiency.

Balance Sheet

The balance sheet for Linc AB is strong with a solid equity base and no debt in 2024. The debt-to-equity ratio is zero, highlighting low financial risk. The equity ratio is high, indicating that the company is well-capitalized. However, previous years show some liabilities, though they remain minimal relative to equity, indicating robust financial health over time.

Cash Flow

Cash flow analysis reveals challenges, with volatility in operating cash flow and free cash flow over recent years. While there is positive free cash flow in 2024, prior years show significant negative cash flows, reflecting instability in cash generation. The operating cash flow to net income ratio suggests inconsistency in converting income into cash, posing risks to liquidity management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	195.24M	1.29B	3.65M	2.37M	4.14M	1.31M
Gross Profit	-21.85M	1.29B	904.00K	-2.66M	-2.44M	150.00K
EBITDA	224.40M	0.00	666.10M	9.75M	-9.67M	970.30M
Net Income	244.33M	1.30B	619.46M	-723.34M	-30.03M	833.18M
Balance Sheet
Total Assets	3.84B	4.84B	3.53B	2.91B	3.76B	2.64B
Cash, Cash Equivalents and Short-Term Investments	505.29M	549.66M	519.98M	600.55M	828.69M	21.91M
Total Debt	0.00	0.00	4.48M	287.00K	127.00K	255.00K
Total Liabilities	5.12M	8.76M	2.92M	2.85M	130.48M	144.17M
Stockholders Equity	3.83B	4.83B	3.53B	2.91B	3.63B	2.49B
Cash Flow
Free Cash Flow	157.37M	29.68M	-80.57M	-228.15M	-353.84M	-14.63M
Operating Cash Flow	157.37M	29.68M	-80.57M	-228.15M	-353.84M	-14.63M
Investing Cash Flow	1.09B	0.00	0.00	-199.75M	-339.45M	-6.38M
Financing Cash Flow	-19.33M	0.00	0.00	-5.00M	1.16B	-7.65M

Linc AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 73.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LINC, the sentiment is Positive. The current price of 73.2 is above the 20-day moving average (MA) of 70.95, above the 50-day MA of 69.27, and below the 200-day MA of 75.85, indicating a bullish trend. The MACD of 1.25 indicates Negative momentum. The RSI at 70.80 is Negative, neither overbought nor oversold. The STOCH value of 95.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:LINC.

Linc AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	kr119.76B	25.08	7.49%	4.19%	13.90%	-82.08%
SVOL.B	64 Neutral	€5.82B	13.31	-3.12%	3.05%	―	―
IDUN.B	63 Neutral	kr4.02B	101.87	7.13%	0.28%	2.42%	20.90%
MCAP	62 Neutral	kr7.25B	35.78	16.42%	―	10.18%	-1.08%
LINC	57 Neutral	kr4.42B	18.08	5.76%	―	37.32%	-39.07%
BURE	56 Neutral	kr21.49B	185.23	0.27%	0.95%	13.61%	-97.82%